Literature DB >> 23839274

Use of ambulatory blood pressure monitoring to guide hypertensive therapy.

Amita Singh1, Eugenia Gianos, Arthur Schwartzbard, Henry Black, Howard Weintraub.   

Abstract

OPINION STATEMENT: With the advent of noninvasive 24-hour ambulatory blood pressure monitoring (ABPM), clinicians have access to a wealth of individualized data for the hypertensive patient. This has led to a greater understanding of the pathophysiology of hypertension and its complications. This tool has provided more precise diagnostic criteria for hypertension and helped discover those with white coat and masked hypertension. Patterns noted on ABPM and correlated with outcomes have allowed for more accurate identification of patients at high risk of cardiovascular (CV) events, and have offered an additional prognostic tool. In addition, ABPM allows for the assessment of the efficacy and adequacy of blood pressure treatment. In the current paper, we will describe the essential components of ABPM, review the evidence detailing the prognostic information that can be derived from its use, highlight clinical scenarios wherein ABPM can offer invaluable diagnostic information, and describe applications of ABPM that evaluate the efficacy of treatment of the hypertensive patient.

Entities:  

Year:  2013        PMID: 23839274     DOI: 10.1007/s11936-013-0255-4

Source DB:  PubMed          Journal:  Curr Treat Options Cardiovasc Med        ISSN: 1092-8464


  83 in total

1.  Alteration of circadian time structure of blood pressure caused by night shift schedule.

Authors:  Y Motohashi; S Higuchi; A Maeda; Y Liu; T Yuasa; K Motohashi; K Nakamura
Journal:  Occup Med (Lond)       Date:  1998-11       Impact factor: 1.611

2.  Home versus ambulatory blood pressure monitoring in the diagnosis of clinic resistant and true resistant hypertension.

Authors:  E G Nasothimiou; D Tzamouranis; L G Roussias; G S Stergiou
Journal:  J Hum Hypertens       Date:  2011-11-10       Impact factor: 3.012

3.  The epidemiology of coronary heart disease--the Framingham enquiry.

Authors:  T R DAWBER; W B KANNEL; N REVOTSKIE; A KAGAN
Journal:  Proc R Soc Med       Date:  1962-04

4.  Probability of stroke: a risk profile from the Framingham Study.

Authors:  P A Wolf; R B D'Agostino; A J Belanger; W B Kannel
Journal:  Stroke       Date:  1991-03       Impact factor: 7.914

5.  Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.

Authors:  S Yusuf; P Sleight; J Pogue; J Bosch; R Davies; G Dagenais
Journal:  N Engl J Med       Date:  2000-01-20       Impact factor: 91.245

6.  Day-night dip and early-morning surge in blood pressure in hypertension: prognostic implications.

Authors:  Paolo Verdecchia; Fabio Angeli; Giovanni Mazzotta; Marta Garofoli; Elisa Ramundo; Giorgio Gentile; Giuseppe Ambrosio; Gianpaolo Reboldi
Journal:  Hypertension       Date:  2012-05-14       Impact factor: 10.190

7.  Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.

Authors:  J A Staessen; R Fagard; L Thijs; H Celis; G G Arabidze; W H Birkenhäger; C J Bulpitt; P W de Leeuw; C T Dollery; A E Fletcher; F Forette; G Leonetti; C Nachev; E T O'Brien; J Rosenfeld; J L Rodicio; J Tuomilehto; A Zanchetti
Journal:  Lancet       Date:  1997-09-13       Impact factor: 79.321

8.  Prognostic accuracy of day versus night ambulatory blood pressure: a cohort study.

Authors:  José Boggia; Yan Li; Lutgarde Thijs; Tine W Hansen; Masahiro Kikuya; Kristina Björklund-Bodegård; Tom Richart; Takayoshi Ohkubo; Tatiana Kuznetsova; Christian Torp-Pedersen; Lars Lind; Hans Ibsen; Yutaka Imai; Jiguang Wang; Edgardo Sandoya; Eoin O'Brien; Jan A Staessen
Journal:  Lancet       Date:  2007-10-06       Impact factor: 79.321

9.  Does white coat hypertension require treatment over age 80?: Results of the hypertension in the very elderly trial ambulatory blood pressure side project.

Authors:  Christopher J Bulpitt; Nigel Beckett; Ruth Peters; Jan A Staessen; Ji-Guang Wang; Marius Comsa; Robert H Fagard; Dan Dumitrascu; Vesselka Gergova; Riitta L Antikainen; Elizabeth Cheek; Chakravarthi Rajkumar
Journal:  Hypertension       Date:  2012-11-19       Impact factor: 10.190

10.  Risers and extreme-dippers of nocturnal blood pressure in hypertension: antihypertensive strategy for nocturnal blood pressure.

Authors:  Kazuomi Kario; Kazuyuki Shimada
Journal:  Clin Exp Hypertens       Date:  2004-02       Impact factor: 1.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.